妊娠期镰状细胞病女性的肺部并发症:系统综述与荟萃分析
结果显示,妊娠合并镰状细胞病者发生肺血栓栓塞的风险显著增加(RR 7.74;95%CI 4.65-12.89),急性胸部综合征和肺炎的估计患病率为6.46%(95%CI 4.66%-8.25%),HbSS与HbSC基因型间无显著差异(RR 1.42;95%CI 0.90-2.23)。
要点
- 妊娠合并镰状细胞病者肺血栓栓塞风险显著升高(RR 7.74)。
- 急性胸部综合征和肺炎估计患病率为6.46%。
- HbSS与HbSC基因型间肺部并发症风险无显著差异。
核心结论
- 妊娠合并镰状细胞病与母亲肺部并发症存在强关联,尤其肺血栓栓塞风险显著增加。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE、Web of Science、Cochrane及Maternity and Infant Care数据库1998年1月至2019年4月发表的观察性研究,纳入至少30名参与者。
主要发现
- 与无镰状细胞病的孕妇相比,妊娠合并镰状细胞病者肺血栓栓塞风险增加(RR 7.74;95%CI 4.65-12.89)。
- 急性胸部综合征和肺炎的估计患病率为6.46%(95%CI 4.66%-8.25%)。
- HbSS与HbSC基因型间急性胸部综合征和肺炎风险无显著差异(RR 1.42;95%CI 0.90-2.23)。
临床怎么用
- 了解镰状细胞病妊娠相关肺部并发症风险有助于孕前咨询和妊娠期优化管理,以降低母亲发病率和死亡率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sickle cell disease (SCD) is a multisystem disease characterised by vaso-occlusive crisis, chronic anaemia and a shorter lifespan. More patients with SCD are living till reproductive age and contemplating pregnancy. Pulmonary complications in pregnancy are significant causes of maternal morbidity and mortality but yet this has not been systematically quantified. A systematic review and meta-analysis were conducted to quantify the association between SCD and pulmonary complications in pregnancy. METHODS: MEDLINE, EMBASE, Web of Science, Cochrane and Maternity and Infant Care databases were searched for publications between January 1998 and April 2019. Observational studies involving at least 30 participants were included. Random-effects models were used for statistical meta-analysis. FINDINGS: Twenty-two studies were included in the systematic review and 18 in the quantitative analysis. The meta-analysis included 3964 pregnancies with SCD and 336 559 controls. Compared with women without SCD, pregnancies complicated by SCD were at increased risk of pulmonary thromboembolism (relative risk (RR) 7.74; 95% CI 4.65 to 12.89). The estimated prevalence of acute chest syndrome and pneumonia was 6.46% (95% CI 4.66% to 8.25%), with no significant difference between the HbSS and HbSC genotypes (RR 1.42; 95% CI 0.90 to 2.23). INTERPRETATION: This meta-analysis highlighted a strong association between SCD and maternal pulmonary complications. Understanding the risks of and the factors associated with pulmonary complications would aid preconceptual counselling and optimal management of the condition in pregnancy, thereby reducing associated maternal morbidity and mortality. PROSPERO REGISTRATION NUMBER: CRD42019124708.
引用
- Inparaj S, Buckingham M, Oakley L, et al. Pulmonary complications for women with sickle cell disease in pregnancy: systematic review and meta-analysis. Thorax. 2020. PMID: 32345690. doi:10.1136/thoraxjnl-2019-213796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。